E
Erik B. Schelbert
Researcher at University of Pittsburgh
Publications - 140
Citations - 7144
Erik B. Schelbert is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 32, co-authored 120 publications receiving 5229 citations. Previous affiliations of Erik B. Schelbert include Cardiovascular Institute of the South & University of Michigan.
Papers
More filters
Journal ArticleDOI
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)
Daniel Messroghli,James C. Moon,Vanessa M Ferreira,Lars Grosse-Wortmann,Taigang He,Peter Kellman,Julia Mascherbauer,Reza Nezafat,Michael Salerno,Erik B. Schelbert,Andrew J. Taylor,Richard B. Thompson,Martin Ugander,Ruud B. van Heeswijk,Matthias G. Friedrich +14 more
TL;DR: This document provides a summary of the existing evidence for the clinical value of parametric mapping in the heart as of mid 2017, and gives recommendations for practical use in different clinical scenarios for scientists, clinicians, and CMR manufacturers.
Journal ArticleDOI
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
James C. Moon,Daniel Messroghli,Peter Kellman,Stefan K. Piechnik,Matthew D. Robson,Martin Ugander,Peter D. Gatehouse,Andrew E. Arai,Matthias G. Friedrich,Stefan Neubauer,Jeanette Schulz-Menger,Jeanette Schulz-Menger,Erik B. Schelbert +12 more
TL;DR: This document provides recommendations for clinical and research T1 and ECV measurement, based on published evidence when available and expert consensus when not, and addresses controversies in the field.
Journal ArticleDOI
Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality
Timothy C. Wong,Kayla Piehler,Christopher G Meier,Stephen M Testa,Amanda M. Klock,Ali A. Aneizi,Jonathan Shakesprere,Peter Kellman,Sanjeev G. Shroff,David Schwartzman,Suresh Mulukutla,Marc A. Simon,Erik B. Schelbert +12 more
TL;DR: ECV measures of extracellular matrix expansion may predict mortality as well as other composite end points (death/cardiac transplant/left ventricular assist device implantation) and Cox regression models.
Journal ArticleDOI
Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives
TL;DR: Current knowledge of the mechanisms and detrimental consequences of myocardial interstitial fibrosis are summarized, the potential of circulating and imaging biomarkers available to recognize different phenotypes of this lesion and track their clinical evolution are discussed, and the currently available and potential future therapies that allow its individualized management in heart failure patients are reviewed.
Journal ArticleDOI
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission
Timothy C. Wong,Kayla Piehler,Ian A. Kang,Ajay Kadakkal,Peter Kellman,David Schwartzman,Suresh Mulukutla,Marc A. Simon,Sanjeev G. Shroff,Lewis H. Kuller,Erik B. Schelbert +10 more
TL;DR: Extracellular volume fraction detects amelioration of ECM expansion associated with RAAS blockade, and is associated with mortality and/or incident hospitalization for heart failure in diabetic individuals.